||6-Iodo-quinazoline-2,4-diamine; 2,4-Quinazolinediamine, 6-iodo-; Aids007473; Aids-007473
||Data not available, please inquire.
1.Design, synthesis and antiproliferative activity of novel 5-nitropyrimidine-2,4-diamine derivatives bearing alkyl acetate moiety.
Zhao PL1, Li YH2, Yang HK2, Chen P2, Zhang B2, Sun Q2, Li Q2, You WW3. Eur J Med Chem. 2016 Apr 16;118:161-169. doi: 10.1016/j.ejmech.2016.04.038. [Epub ahead of print]
In order to discover new anticancer drug leads, a series of novel alkylamino pyrimidine derivatives were designed and synthesized based on our previous work via a ring-opening strategy. Biological evaluation with four human cancer cell lines (MDA-MB-231, A549, HepG2, and MCF-7) showed that most of these compounds possessed moderate to potent antiproliferative activities. The most promising compound 7w displayed a three-fold improvement compared with commercial anticancer drug fluorouracil in inhibiting HepG2 cell proliferation with IC50 value of 10.37 μM. Moreover, flow-activated cell sorting analysis suggested that compound 7w mainly arrested HepG2 cells in G2/M stage. Hence, it could serve as a promising lead for the design of novel anticancer small-molecule drugs.